30th Nov 2015 08:46
LONDON (Alliance News) - Quantum Pharma PLC on Monday said it has secured three new out-licensing deals in Germany through its Lamda unit within its niche pharmaceuticals division.
Quantum said under the three deals, Lamda will out-licence two generic plus and one generic dossier that it developed. It will get a total of EUR375,000 in fees from the deal.
"Through these deals and the associated supply agreements, Lamda continues to build a sustainable and profitable revenue stream, which we expect will continue to grow over the coming years," said Quantum Chief Executive Andrew Scaife.
Shares in Quantum were up 1.6% to 98.00 pence early Monday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Quantum Pharma